1. Home
  2. HRMY vs GEL Comparison

HRMY vs GEL Comparison

Compare HRMY & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HRMY
  • GEL
  • Stock Information
  • Founded
  • HRMY 2017
  • GEL 1996
  • Country
  • HRMY United States
  • GEL United States
  • Employees
  • HRMY N/A
  • GEL N/A
  • Industry
  • HRMY Biotechnology: Pharmaceutical Preparations
  • GEL Oil Refining/Marketing
  • Sector
  • HRMY Health Care
  • GEL Energy
  • Exchange
  • HRMY Nasdaq
  • GEL Nasdaq
  • Market Cap
  • HRMY 1.8B
  • GEL 1.6B
  • IPO Year
  • HRMY 2020
  • GEL 1996
  • Fundamental
  • Price
  • HRMY $34.00
  • GEL $17.11
  • Analyst Decision
  • HRMY Strong Buy
  • GEL Buy
  • Analyst Count
  • HRMY 9
  • GEL 3
  • Target Price
  • HRMY $54.44
  • GEL $16.50
  • AVG Volume (30 Days)
  • HRMY 642.5K
  • GEL 606.7K
  • Earning Date
  • HRMY 08-05-2025
  • GEL 07-31-2025
  • Dividend Yield
  • HRMY N/A
  • GEL 3.83%
  • EPS Growth
  • HRMY 13.13
  • GEL N/A
  • EPS
  • HRMY 2.62
  • GEL N/A
  • Revenue
  • HRMY $744,852,000.00
  • GEL $2,930,080,000.00
  • Revenue This Year
  • HRMY $20.10
  • GEL N/A
  • Revenue Next Year
  • HRMY $18.01
  • GEL $5.69
  • P/E Ratio
  • HRMY $13.10
  • GEL N/A
  • Revenue Growth
  • HRMY 20.62
  • GEL 3.87
  • 52 Week Low
  • HRMY $26.47
  • GEL $9.86
  • 52 Week High
  • HRMY $41.61
  • GEL $17.59
  • Technical
  • Relative Strength Index (RSI)
  • HRMY 58.91
  • GEL 55.68
  • Support Level
  • HRMY $31.70
  • GEL $17.18
  • Resistance Level
  • HRMY $35.08
  • GEL $17.59
  • Average True Range (ATR)
  • HRMY 0.95
  • GEL 0.47
  • MACD
  • HRMY 0.27
  • GEL -0.04
  • Stochastic Oscillator
  • HRMY 71.80
  • GEL 60.25

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About GEL Genesis Energy L.P. Common Units

Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.

Share on Social Networks: